Med. praxi. 2026;23(1):52-56

Kardiovaskulární prevence v linii s národním kardiovaskulárním plánem

MUDr. Zuzana Zafarová

Zaznělo na 11. kongrese Medicíny pro praxi v Plzni, 21.-22. listopadu 2025. Zpracováno na základě přednášky MUDr. Markéty Ječmenové, InterMedCare s. r. o., Interní kardiologická ambulance Brno.

Published: March 3, 2026  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Zafarová Z. Kardiovaskulární prevence v linii s národním kardiovaskulárním plánem. Med. praxi. 2026;23(1):52-56.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Purchase PDF - 60 CZK (2.5 EUR)
    will be unlocked 3.3.2027

    References

    1. Terentes-Printzios D, Vlachopoulos C, et al. Cardiovascular Risk Factors Accelerate Progression of Vascular Aging in the General Population: Results From the CRAVE Study (Cardiovascular Risk Factors Affecting Vascular Age). Hypertension. 2017 Nov;70(5):1057-1064. doi: 10.1161/HYPERTENSIONAHA.117.09633. Epub 2017 Sep 18. PMID: 28923899. Go to original source... Go to PubMed...
    2. Mach F, Baigent C, Catapano AL, et al. ESC Scientific Document Group. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J. 2020 Jan 1;41(1):111-188. doi: 10.1093/eurheartj/ehz455. Erratum in: Eur Heart J. 2020 Nov 21;41(44):4255. doi: 10.1093/eurheartj/ehz826. PMID: 31504418. Go to original source... Go to PubMed...
    3. Laufs U, Descamps OS, Catapano AL, et al. Understanding IMPROVE-IT and the cardinal role of LDL-C lowering in CVD prevention. Eur Heart J. 2014 Aug 7;35(30):1996-2000. doi: 10.1093/eurheartj/ehu228. Epub 2014 Jun 10. PMID: 24917645. Go to original source... Go to PubMed...
    4. Emberson J, Whincup P, Morris R, et al. Evaluating the impact of population and high-risk strategies for the primary prevention of cardiovascular disease. Eur Heart J. 2004 Mar;25(6):484-91. doi: 10.1016/j.ehj.2003.11.012. PMID: 15039128. Go to original source... Go to PubMed...
    5. Cicero AFG, Fogacci F, Rizzoli E, et al. Brisighella Heart Study Group. Impact of simultaneous management of hypertension and hypercholesterolemia with ACE inhibitors and statins on cardiovascular outcomes in the Brisighella Heart Study: A 8-year follow-up. Nutr Metab Cardiovasc Dis. 2022 Sep;32(9):2246-2254. doi: 10.1016/j.numecd.2022.06.017. Epub 2022 Jun 30. PMID: 35843791. Go to original source...
    6. Thoenes M, Bramlage P, Zhong S, et al. Hypertension control and cardiometabolic risk: a regional perspective. Cardiol Res Pract. 2012;2012:925046. doi: 10.1155/2012/925046. Epub 2012 Jan 2. PMID: 22242212; PMCID: PMC3254169. Go to original source... Go to PubMed...
    7. Visseren FLJ, Mach F, Smulders YM, et al. ESC Scientific Document Group. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021 Sep 7;42(34):3227-3337. doi:10.1093/eurheartj/ehab484. Go to original source... Go to PubMed...

    Return to the content


    Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.